| Cat.No.: | EL-0361 |
| Product Name: | NIH:OVCAR-3 nuclear extract |
| Description: | NIH:OVCAR-3 nuclear extract was prepared from cell cultures of the human ovarian carcinoma NIH:OVCAR-3 cell line. The NIH:OVCAR-3 cell line was derived from malignant ascites of a 60 year old Caucasian female patient with progressive adenocarcinoma of the ovary who underwent combination chemotherapy treatment with cyclophosphamide, Adriamycin, and cisplatin. NIH:OVCAR-3 cultured cells are epithelial in morphology and are characterized by the expression of cytoplasmic androgen and estrogen specific receptor molecules. They are tumorigenic in athymic mice and have an abnormal karyotype. These cells are resistant to clinically relevant concentrations of Adriamycin, melphalan and cisplatin chemotherapies. NIH:OVCAR-3 cells are most commonly used in research as a model for ovarian carcinoma and to study the efficacy of hormone cancer therapies. |
| Species: | Human |
| Source: | Human ovary adenocarcinoma |
| Components: | 200 µg of NIH:OVCAR-3 nuclear extract at 6.52 µg/µl. |
| Extract Composition: | NIH:OVCAR-3 nuclear extract is supplied in Dilution Buffer (20 mM Hepes (pH 7.9), 100 mM KCl, 1 mM MgCl2, 20% glycerol, 0.5 mM PMSF and 0.5 mM DTT). |
| Application Notes: | NIH:OVCAR-3 nuclear extract is specifically recommended for ovarian cancer and hormone therapy studies. |
| Storage: | Store at -80°C. Aliquot to avoid repeated freezing and thawing. |
| Warning: | For research use only, not for diagnostic or therapeutic use. |
| Product Types | ||
| ◆ Extracts & Lysates | ||
| EL-0001 | Recombinant Human MBD1 Cell Lysate | Inquiry |
| EL-0002 | Recombinant Human MBD3 Cell Lysate | Inquiry |
| EL-0003 | Recombinant Human MBD3L1 293 Cell Lysate | Inquiry |
| EL-0004 | Recombinant Human MBD4 Lysate | Inquiry |
| EL-0005 | Recombinant Human MBD5 Cell Lysate | Inquiry |
USA
Enter your email here to subscribe.
Follow us on
Easy access to products and services you need from our library via powerful searching tools
